11.82
price down icon1.75%   -0.21
after-market 시간 외 거래: 11.56 -0.26 -2.20%
loading
전일 마감가:
$12.03
열려 있는:
$12.47
하루 거래량:
322.03K
Relative Volume:
0.78
시가총액:
$320.56M
수익:
$157.75M
순이익/손실:
$-29.73M
주가수익비율:
-10.19
EPS:
-1.16
순현금흐름:
$-21.00M
1주 성능:
-2.72%
1개월 성능:
-7.80%
6개월 성능:
-32.50%
1년 성능:
-69.23%
1일 변동 폭
Value
$11.70
$12.50
1주일 범위
Value
$11.70
$13.00
52주 변동 폭
Value
$8.04
$45.00

Arcturus Therapeutics Holdings Inc Stock (ARCT) Company Profile

Name
명칭
Arcturus Therapeutics Holdings Inc
Name
전화
(858) 900-2660
Name
주소
10628 SCIENCE CENTER DRIVE, SAN DIEGO, CA
Name
직원
176
Name
트위터
@ArcturusRx
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
ARCT's Discussions on Twitter

ARCT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ARCT
Arcturus Therapeutics Holdings Inc
11.82 329.52M 157.75M -29.73M -21.00M -1.16
Biotechnology icon
ONC
Beigene Ltd Adr
240.41 25.57B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.10 111.79B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.30 39.90M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
591.85 65.28B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
73.93 6.31B 0 -153.72M -103.81M -2.00

Arcturus Therapeutics Holdings Inc Stock (ARCT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-01-28 개시 BTIG Research Buy
2024-08-12 개시 Leerink Partners Outperform
2023-12-13 개시 Canaccord Genuity Buy
2023-07-24 개시 William Blair Outperform
2023-05-11 업그레이드 H.C. Wainwright Neutral → Buy
2022-11-14 재개 Wells Fargo Overweight
2022-11-10 다운그레이드 Robert W. Baird Neutral → Underperform
2022-11-03 업그레이드 Citigroup Neutral → Buy
2022-11-02 업그레이드 Barclays Underweight → Equal Weight
2022-08-10 다운그레이드 Raymond James Mkt Perform → Underperform
2022-07-19 재개 Cantor Fitzgerald Overweight
2022-05-11 업그레이드 Robert W. Baird Underperform → Neutral
2022-04-21 다운그레이드 Citigroup Buy → Neutral
2022-01-31 업그레이드 Raymond James Underperform → Mkt Perform
2021-08-12 다운그레이드 Raymond James Mkt Perform → Underperform
2021-08-11 다운그레이드 Goldman Neutral → Sell
2021-08-10 다운그레이드 Robert W. Baird Neutral → Underperform
2021-07-02 개시 Cantor Fitzgerald Overweight
2021-06-25 재개 Goldman Neutral
2021-06-21 다운그레이드 Barclays Equal Weight → Underweight
2021-06-04 재개 Robert W. Baird Neutral
2021-02-17 다운그레이드 B. Riley Securities Neutral → Sell
2021-01-19 다운그레이드 B. Riley Securities Buy → Neutral
2021-01-15 다운그레이드 B. Riley Securities Buy → Neutral
2021-01-07 개시 Wells Fargo Overweight
2020-12-29 다운그레이드 Barclays Overweight → Equal Weight
2020-12-29 다운그레이드 H.C. Wainwright Buy → Neutral
2020-12-29 다운그레이드 Raymond James Outperform → Mkt Perform
2020-12-29 다운그레이드 Robert W. Baird Outperform → Neutral
2020-12-23 다운그레이드 ROTH Capital Buy → Sell
2020-12-08 재확인 B. Riley Securities Buy
2020-12-07 재확인 B. Riley Securities Buy
2020-10-26 개시 Barclays Overweight
2020-10-06 개시 Citigroup Buy
2020-08-26 개시 Piper Sandler Overweight
2020-07-30 재개 ROTH Capital Buy
2020-07-16 개시 Raymond James Outperform
2020-07-13 개시 B. Riley FBR Buy
2020-06-09 다운그레이드 WBB Securities Buy → Hold
2020-02-11 개시 Robert W. Baird Outperform
2020-02-07 개시 Guggenheim Buy
2020-02-06 개시 Guggenheim Buy
2019-04-05 개시 H.C. Wainwright Buy
2018-09-20 업그레이드 WBB Securities Buy → Strong Buy
2018-01-22 개시 Chardan Capital Markets Buy
모두보기

Arcturus Therapeutics Holdings Inc 주식(ARCT)의 최신 뉴스

pulisher
02:28 AM

When the Price of (ARCT) Talks, People Listen - news.stocktradersdaily.com

02:28 AM
pulisher
12:39 PM

Scotiabank Initiates Coverage on Arcturus Therapeutics (ARCT) | - GuruFocus

12:39 PM
pulisher
07:31 AM

Arcturus Therapeutics (ARCT) Receives Positive Outlook with Potential Upside | ARCT Stock News - GuruFocus

07:31 AM
pulisher
07:12 AM

Scotiabank Initiates Arcturus Therapeutics at Outperform - marketscreener.com

07:12 AM
pulisher
May 27, 2025

Man Group plc Sells 4,168 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

May 27, 2025
pulisher
May 24, 2025

Arcturus Therapeutics’ SWOT analysis: mRNA innovator’s stock faces pivotal year - Investing.com

May 24, 2025
pulisher
May 24, 2025

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Given Average Recommendation of “Buy” by Brokerages - Defense World

May 24, 2025
pulisher
May 24, 2025

Wall Street Zen Upgrades Arcturus Therapeutics (NASDAQ:ARCT) to “Hold” - Defense World

May 24, 2025
pulisher
May 22, 2025

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: A 481% Upside Potential Amidst Biotech Innovations - DirectorsTalk Interviews

May 22, 2025
pulisher
May 22, 2025

Northern Trust Corp Has $4.35 Million Stock Position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

May 22, 2025
pulisher
May 18, 2025

Trend Tracker for (ARCT) - news.stocktradersdaily.com

May 18, 2025
pulisher
May 17, 2025

Wells Fargo & Company Cuts Arcturus Therapeutics (NASDAQ:ARCT) Price Target to $45.00 - Defense World

May 17, 2025
pulisher
May 16, 2025

Arcturus signals extended cash runway into 2028 with strategic shift toward CF and OTC mRNA therapeutics - MSN

May 16, 2025
pulisher
May 16, 2025

FY2025 EPS Estimates for ARCT Raised by Cantor Fitzgerald - The AM Reporter

May 16, 2025
pulisher
May 16, 2025

Leerink Partnrs Analysts Raise Earnings Estimates for ARCT - Defense World

May 16, 2025
pulisher
May 16, 2025

Price T Rowe Associates Inc. MD Increases Stock Position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

May 16, 2025
pulisher
May 16, 2025

William Blair Brokers Boost Earnings Estimates for ARCT - Defense World

May 16, 2025
pulisher
May 15, 2025

Wall Street Analysts Believe Arcturus Therapeutics (ARCT) Could Rally 503.6%: Here's is How to Trade - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Canaccord Genuity Group Issues Pessimistic Forecast for Arcturus Therapeutics (NASDAQ:ARCT) Stock Price - Defense World

May 15, 2025
pulisher
May 14, 2025

Arcturus Therapeutics (ARCT): Wells Fargo Maintains Rating, Lowe - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q1 2025 Earnings Call Transcript - Insider Monkey

May 14, 2025
pulisher
May 14, 2025

Wells Fargo Adjusts Price Target for Arcturus Therapeutics (ARCT - GuruFocus

May 14, 2025
pulisher
May 13, 2025

Arcturus Therapeutics (ARCT) Set for Potential Upside with Citi's Confidence | ARCT Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Arcturus Therapeutics Holdings Inc earnings missed by $4.11, revenue fell short of estimates - Investing.com Nigeria

May 13, 2025
pulisher
May 13, 2025

Canaccord Genuity Maintains Buy Rating on Arcturus Therapeutics (ARCT) | ARCT Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Demystifying Arcturus Therapeutics: Insights From 7 Analyst Reviews - Benzinga

May 13, 2025
pulisher
May 13, 2025

Arcturus Therapeutics (ARCT) Price Target Revised by Canaccord | - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Arcturus Therapeutics Holdings Inc (ARCT) Q1 2025 Earnings: EPS - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Arcturus Therapeutics Holdings Inc (ARCT) Q1 2025 Earnings Call Highlights: Strategic Focus and ... - Yahoo Finance

May 13, 2025
pulisher
May 13, 2025

Arcturus Therapeutics Holdings Inc (ARCT) Q1 2025 Earnings Call - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Arcturus Therapeutics Reports Q1 2025 Financial Update - TipRanks

May 13, 2025
pulisher
May 12, 2025

Arcturus Therapeutics (ARCT) Sees Strong Progress with Pipeline Programs - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Earnings call transcript: Arcturus Therapeutics Q1 2025 sees revenue drop, stock rises - Investing.com

May 12, 2025
pulisher
May 12, 2025

Arcturus Therapeutics (ARCT) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 12, 2025
pulisher
May 12, 2025

Arcturus Therapeutics Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025
pulisher
May 12, 2025

Arcturus Therapeutics (ARCT) Surpasses Q1 Revenue Expectations | - GuruFocus

May 12, 2025
pulisher
May 12, 2025

ARCTURUS THERAPEUTICS Earnings Results: $ARCT Reports Quarterly Earnings - Nasdaq

May 12, 2025
pulisher
May 12, 2025

Arcturus Therapeutics stock jumps 7% despite Q1 loss By Investing.com - Investing.com Canada

May 12, 2025
pulisher
May 12, 2025

Arcturus Therapeutics stock jumps 7% despite Q1 loss - Investing.com Australia

May 12, 2025
pulisher
May 12, 2025

Arcturus Therapeutics: Q1 Earnings Snapshot - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

Arcturus Therapeutics Announces First Quarter 2025 Financial Update and Pipeline Progress - Business Wire

May 12, 2025
pulisher
May 10, 2025

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Shares Sold by Dimensional Fund Advisors LP - Defense World

May 10, 2025
pulisher
May 10, 2025

Arcturus Therapeutics (ARCT) to Release Quarterly Earnings on Monday - Defense World

May 10, 2025
pulisher
May 09, 2025

Earnings To Watch: Arcturus Therapeutics Holdings Inc (ARCT) Reports Q1 2025 Result - Yahoo Finance

May 09, 2025
pulisher
May 08, 2025

MetLife Investment Management LLC Has $283,000 Holdings in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

May 08, 2025
pulisher
May 06, 2025

Barclays PLC Sells 7,333 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

May 06, 2025
pulisher
May 05, 2025

Earnings Preview: Arcturus Therapeutics (ARCT) Q1 Earnings Expected to Decline - Yahoo Finance

May 05, 2025
pulisher
May 04, 2025

Arcturus Therapeutics Holdings Inc.'s (NASDAQ:ARCT) Price Is Right But Growth Is Lacking After Shares Rocket 41% - simplywall.st

May 04, 2025

Arcturus Therapeutics Holdings Inc (ARCT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$1.05
price down icon 8.70%
$30.28
price down icon 2.39%
$576.24
price down icon 0.61%
$285.56
price down icon 1.56%
$4.35
price up icon 1.64%
$73.93
price down icon 2.22%
자본화:     |  볼륨(24시간):